key: cord-0687176-xvua3cld
authors: Wiedemann, Dominik; Bernardi, Martin H.; Distelmaier, Klaus; Goliasch, Georg; Hengstenberg, Christian; Hermann, Alexander; Holzer, Michael; Hoetzenecker, Konrad; Klepetko, Walter; Lang, György; Lassnigg, Andrea; Laufer, Günther; Magnet, Ingrid A. M.; Markstaller, Klaus; Röggla, Martin; Rössler, Bernhard; Schellongowski, Peter; Simon, Paul; Tschernko, Edda; Ullrich, Roman; Zimpfer, Daniel; Staudinger, Thomas
title: Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: Consensus paper of the Medical University of Vienna
date: 2020-07-03
journal: Wien Klin Wochenschr
DOI: 10.1007/s00508-020-01708-8
sha: 40a21f5aad8dcc3c02b201e7bf6070f974390e1d
doc_id: 687176
cord_uid: xvua3cld

The pandemic from the SARS-CoV‑2 virus is currently challenging healthcare systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe working environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develop respiratory or circulatory failure that is refractory to conventional treatment, it is of utmost importance to clearly define criteria for the use of ECMO in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.

distress syndrome (ARDS) [2, 3] . Moreover, cardiac involvement leading to fulminant myocarditis, arrhythmia, and circulatory failure has been described [3, 4] . Once COVID-19 patients require mechanical ventilation, mortality rates increase dramatically.

Despite the fact that in the USA, Spain and Italy (the countries with the highest numbers of COVID-19 patients at the time this document was created) the number of ECMO patients among COVID-19 cases is low, it seems of outmost importance to address this issue in Austria and Vienna by establishing recommendations for ECMO support in COVID-19 patients.

For additional/general information on this topic please refer to the guidelines of the Extracorporeal Life Support Organization (ELSO) [5] .

Whereas in more affected countries triaging of patients to give treatment priority to those with more chances of survival has already become standard practice, triage is not necessary in Austria so far. Nevertheless, indications for ECMO support in COVID-19 should be defined restrictively under consideration of possible future resource shortages [6] , which does not generally imply an exclusion of COVID-19 patients from ECMO treatment; however, advanced age, comorbidities and conditions limiting prognosis in general are important factors, which have to be taken into consideration before initiation of ECMO support in COVID-19 patients.

If the situation in Austria changes and a triage is necessary similar to Italy, Spain and other countries, the decision for ECMO support will be made according to the available resources, especially with respect to availability of intensive care unit (ICU) beds and mechanical ventilation.

The number of hospitals offering ECMO is increasing steadily [7] ; however, the start of novel ECMO programs is currently not recommended as high volume and profound clinical experience are important factors of clinical outcome [5, 8] . Moreover, the infection risk for staff members is definitely lower when an experienced team is available. Of note: safety first. Especially in a pandemic, the protection of healthcare workers is of outmost importance and has to be prioritized even over the patient's condition.

Since Austria is currently not in need of triage, the decision regarding ECMO implementation should be taken according to the algorithms prior to the pandemic; however, if the COVID-19 pandemic leads to significant resource shortages it might be necessary to make more restrictive decisions also for non-Covid-19 patients.

Especially during the pandemic, patient prioritization is crucial. First come-first served motivated decisions should be avoided due to resource consumption of patients with worse prognosis, potentially resulting in shortages for those with better prognosis. This is of outmost importance because present decisions may have significant impact on future resource availability. Young patients without comorbidities should have the highest priority.

With dynamic changes of capacities during the course of the pandemic, prioritization should be adapted and changed accordingly. Even adaptation of decision pathways from one shift to another seems possible in extreme situations.

If a SARS-CoV-2 positive patient is judged as potential ECMO candidate outside of the Vienna General Hospital (AKH-Wien) according to given criteria, the AKH intensive care coordinator (an experienced intensivist with 24/7 availability) is the first to contact.

For ECMO implementation, we recommend to follow the general guidelines of the Vienna Clinic Network (Wiener Krankenhausverbund, KAV) for personal protection in COVID-19 patients [9] . Additional recommendations for the surgeon to avoid wound infections are to use respirator face masks (FFP-2 or FFP-3) without valves. Alternatively, respirator face masks with valve may be used in combination with standard medical masks.

Exclusion criteria may dynamically change according to resources and capacities. From current perspective, the criteria listed in Table 1 should be used to either exclude or critically evaluate patients for ECMO support.

The use of ECMO in COVID-19 is a rescue treatment, if mechanical ventilation cannot guarantee appropriate gas exchange anymore, resulting in life-threatening or organ-damaging hypoxia and/or hypercapnia; however, ECMO therapy is also indicated when the 

The Extracorporeal Life Support Organization has published a standardized algorithm for the management of ARDS ( Fig. 1 ; [5, 11] ). This algorithm may be of aid to clinicians to evaluate ECMO support in COVID-19 patients under conditions of optimized respiratory treatment. In order to prevent secondary organ damage in time, we recommend early consideration of ECMO treatment. Depending on progress of patient's clinical condition, presentation for ECMO should already be considered in case of progressive respiratory deterioration (PaO2/FiO2 ratio of <150).

Absolute contraindications refer explicitly to patients with severe lung failure due to present SARS-CoV-2 infection. Relative contraindications describe factors associated with a worse outcome in patients with need for respiratory ECMO. In case of present relative contraindications, ECMO treatment should only be applied in exceptional cases! For each point, individual assessment is needed.

The presence of multiple relative contraindications worsens the prediction of patient outcome substantially.

Relative contraindications are evaluated in accordance to resources and capacities. Ideal ECMO candidates would be patients <65 years without pre-existing diseases and single organ failure (lung).

We recommend a cannulation strategy with greatest experience for each center, for example: femorojugular configuration. Cannula size is to be selected according to the expected blood flow demand (goal: ECMO blood flow >60% of the patient's cardiac output). COVID-19 patients qualifying for ECMO are those with the most severe lung failure (rescue ECMO), therefore almost complete lung replacement is to be expected, therefore we recommend to choose a bigger drainage cannula (in normal sized adults with ultrasound assessed venous diameter of ≥10 mm at least 23 F, ideally 25 F). The perfusion cannula chosen is usually 2-4 F smaller in diameter.

In VV ECMO, a lung protective ventilation strategy is recommended including reduction of tidal volumes, driving pressure and respiratory rate [13] [14] [15] . The PEEP titration should be adjusted individually according to the recruitment potential [16] .

Although in COVID-19 patients primarily pulmonary failure is expected, there may be numerous patients requiring VA ECMO support. The underlying causes may be the development of consecutive circulatory failure and also potential primary cardiac involvement with arrythmias or myocarditis. Therefore, in addition to the common hemodynamic monitoring, echocardiography as part of ECMO evaluation in COVID-19 patients is necessary in order to enable the choice between VV and VA ECMO accordingly; however, it has to be pointed out that in pulmonary failure and possibly even high dose vasopressors, but otherwise more or less preserved left and right ventricle function, VA ECMO is not necessarily indicated.

As in non-COVID-19 patients, the cannulation strategy needs to be adapted to the individual clinical scenario. In patients with cardiogenic shock or during resuscitation, percutaneous implantation via the femoral artery and vein is recommended.

An additional cannula for distal leg perfusion is strongly advised in all cases. Due to the fact that most COVID-19 patients have respiratory complications, insufficient oxygenation of the body's upper half based on the Harlequin effect is likely [17] . Therefore, in case of femoro-femoral VA ECMO, oxygenation of the body's upper half needs to be monitored closely by saturation measurement at the right upper limb. In the case of insufficient oxygenation, an early change of the ECMO set-up is recommended. Especially in COVID-19 patients, an upgrading to V-VA ECMO is the primary option to keep a potential contagion risk as low as possible. For V-VA upgrade in such a case an additional cannula is introduced into the jugular vein, which is connected then to the arterial (returning) line. Alternatively, changing the arterial cannulation configuration from femoral to subclavian (axillary) artery is possible; however, as this option is tied to surgical capacities, it involves more healthcare workers and therefore has the higher risk of contagion.

Transesophageal echocardiography (TEE) guided cannula placement is the most established and common imaging modality in our hands; however, TEE is an aerosol-forming procedure, and the advantages need to be balanced against a potential risk of infection. Transthoracic and abdominal ultrasound imaging may be used alternatively.

Some patients with primarily respiratory failure develop right heart failure (ARDS, high PEEP) or left heart failure (myocarditis) during VV ECMO. Therefore, regular monitoring by echocardiography, at least once daily is recommended. In case of evolving heart failure, upgrade or change of the VV ECMO is necessary. The primary choice again is to switch to V-VA ECMO with an additional return cannula inserted in the femoral artery. The second option would be to switch from VV to VA ECMO by cannulation of the subclavian (axillary) artery.

The final decision which approach to choose, is based on the available vascular access as well as the patient's condition and needs to be adjusted to the experience of the individual team on duty.

The Vienna General Hospital runs one of the largest eCPR programs in Europe. While indications and patient selection for eCPR are crucial in general, during a pandemic the available resources and the risk of contagion of healthcare workers are additional factors. The Department of Emergency Medicine of the Medical University of Vienna has established criteria for eCPR in non-COVID-19 patients as illustrated in Table 2 .

Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients Table 2 Criteria for extracorporeal cardiopulmonary resuscitation (eCPR) to facilitate an uncomplicated assessment at an early stage of emergency medical service effort [18] The risk of contagion needs to be assumed as critical for healthcare workers especially in an eCPR setting (aerosol-generating procedure). During eCPR of SARS-CoV-2 positive patients, early (prehospital) contact of the emergency team is important, to enable an out of hospital decision for or against ECMO implementation. Transport of SARS-CoV-2 positive patients to the hospital for eCPR, just to judge them unsuitable for ECMO should be avoided. Healthcare workers would be put at risk for contagion without any prospect of successful treatment.

In case of eCPR of patients with unknown SARS-CoV-2 status (which will most probably be the case), the procedure needs to be performed as if the patients would be SARS-CoV-2 positive (PPE!).

Patients with ECMO in general should be evaluated on a daily basis. During the whole course of the patient PPE needs to be followed. In case of pulmonary and/or cardiac recovery the routine weaning protocol should be followed.

In case of no recovery, even COVID-19 patients should be evaluated for further (permanent) treatment (transplantation or ventricular assist devices). Although, from the current point of view, it is rather unlikely that many COVID-19 will qualify for such a treatment, this option should be evaluated especially in younger patients. Based on recent a publication from our university, we know that the patient's survival chances decrease already after the 7th day on VA ECMO support. This does not mean to stop any ECMO support by day 7, but treatment goals should be re-evaluated after 1 week of ECMO support and further decisions adjusted accordingly [19, 20] .

If there are no options for further treatment modalities, discontinuation of ECMO support needs to be discussed. In respiratory ECMO, a subgroup of patients may recover even after significantly longer support times; therefore, an individual decision to con-tinue ECMO support may be justified (by taking the previous course of organ failure and additional organ failure into account) [21, 22] . These decisions will be dynamically affected by resource shortages and capacities during the pandemic as well. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin

ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases

ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period

Schutzbekleidung bei Corona Virus SARS-COV-2/COVID-19

Frailty predicts 30-day mortality in intensive care patients: A prospective prediction study

Extracorporeal membraneoxygenation for severe acute respiratory distress syndrome

ECMO for ARDS: from salvage to standard of care?

Formal guidelines: management of acute respiratory distress syndrome

An official American Thoracic Society/ European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome

Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis: mechanical ventilation during ECMO

Mechanical ventilation during extracorporeal membrane oxygenation

Assisted beating of the ischemicheart: howto managethepulseless ST-Segmentelevation myocardial infarction patient

Extracorporeal cardiopulmonary resuscitation at the emergency department: a retrospective patient selection evaluation

ELSO general guidelines for all ECLS cases

Useof ECMOin adultpatients withcardiogenic shock: a position paper of the Austrian Society of Cardiology

Outcome of adult respiratory failure patients receiving prolonged (≥14 days) ECMO

Support time-dependent outcome analysis for veno-venous extracorporeal membrane oxygenation